Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system
about
Structure and physiological function of calpainsOrigins of the difference in Ca2+ requirement for activation of mu- and m-calpainDisruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and divisionAnalysis of proteolytic processes and enzymatic activities in the generation of huntingtin n-terminal fragments in an HEK293 cell model.MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activityCharacterization of endogenous and recombinant human calpain-10Electrostatic interactions of domain III stabilize the inactive conformation of mu-calpain.Calpains: intact and active?Purification of native p94, a muscle-specific calpain, and characterization of its autolysisExpression, partial purification and functional properties of themuscle-specific calpain isoform p94.Functional properties of recombinant calpain I and of mutants lacking domains III and IV of the catalytic subunit.Activation of calpain-1 in myelin and microglia in the white matter of the aged rhesus monkey.Possible regulation of the conventional calpain system by skeletal muscle-specific calpain, p94/calpain 3.Age-dependent myelin degeneration and proteolysis of oligodendrocyte proteins is associated with the activation of calpain-1 in the rhesus monkey.Efficient expression and purification of recombinant human μ-calpain using an Escherichia coli expression system.Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib
P2860
Q24530607-834094E1-5BAA-4327-95EA-6E93711F178EQ28217807-2309AFE2-4DF7-473D-990F-3D33C0D69D16Q28512039-047EF592-0AC2-4644-AD00-C2F6151C8044Q34510480-2478327B-53EC-482F-9B77-95023C91671BQ35045715-2F5C29B6-1B92-4FEC-B334-CEDC21769316Q36914839-71BABF46-4BA0-4BDD-98A8-6111F0FCF16DQ40548727-8EB75F7F-82E7-454D-B540-B0A5DE7CDBFEQ41658451-84E94188-CAB9-4260-8C22-0E7E89A5EA26Q41857185-EF692790-CFF0-40A6-B9C8-0CECC442B3C7Q42057938-F4BF4D0C-D0F0-43A6-9B32-CF23BC190F77Q42061565-F2EE51D8-7B84-4912-919B-C6B10E569FE6Q47844787-FAFF3A79-21C0-4479-9D94-A4AEF5CED3B9Q48221842-CAE94C62-8FE3-419F-848D-8B57D0D2D0E7Q48424983-BD636525-0E44-4230-8D95-9446036D7F9DQ50891679-D7B9A439-7176-4EC6-8BFB-D7EE5CA347CAQ57117017-20708FDB-EF5C-4B57-A91E-FA0606E85408
P2860
Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Biologically active monomeric ...... baculovirus expression system
@en
type
label
Biologically active monomeric ...... baculovirus expression system
@en
prefLabel
Biologically active monomeric ...... baculovirus expression system
@en
P2093
P2860
P356
P1433
P1476
Biologically active monomeric ...... baculovirus expression system
@en
P2093
Bihovsky R
Bozyczko-Coyne D
Kaywooya JK
P2860
P304
P356
10.1042/BJ3140511
P407
P478
314 ( Pt 2)
P577
1996-03-01T00:00:00Z